{"disease":{"id":"prostate-cancer-aggressiveness","name":"prostate cancer aggressiveness"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT05384002","title":"An AI Platform Integrating Imaging Data and Models, Supporting Precision Care Through Prostate Cancer's Continuum","phase":"","overall_status":"COMPLETED","enrollment_count":14000,"lead_sponsor_name":"Fondazione del Piemonte per l'Oncologia","has_results":false},{"nct_id":"NCT04052048","title":"Active Surveillance SNEP Assay Registry Trial for Prostate Cancer","phase":"","overall_status":"RECRUITING","enrollment_count":2000,"lead_sponsor_name":"Immunis.AI","has_results":false},{"nct_id":"NCT06662708","title":"Artificial Intelligence Models for Precision Prediction and Treatment of Prostate Cancer","phase":"NA","overall_status":"NOT_YET_RECRUITING","enrollment_count":200,"lead_sponsor_name":"Shao Pengfei","has_results":false},{"nct_id":"NCT03263650","title":"Study of Olaparib Maintenance Following Cabazitaxel-Carbo in Men With AVPC","phase":"PHASE2","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":96,"lead_sponsor_name":"M.D. Anderson Cancer Center","has_results":false}],"total":4},"guidelines":[],"source":"Drug Landscape verified database"}